BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Viking Therapeutics Inc. – Underwriting Agreements

NASDAQ: VKTX    
Share price (11/17/26): $26.88    
Market cap (11/17/26): $3.428 billion

Underwriting Agreements Filter

EX-1.2
from 8-K 57 pages $225,000,000 2.00% Convertible Senior Notes Due 2032 Viking Therapeutics, Inc. Underwriting Agreement September 23, 2026
12/34/56
EX-1.1
from 8-K 54 pages 7,857,143 Shares Viking Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement September 23, 2026
12/34/56
EX-1.1
from 8-K 44 pages 6,471,000 Shares Viking Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1
from 8-K 37 pages Viking Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1.2
from S-3 26 pages Viking Therapeutics, Inc. Common Stock ($0.00001 Par Value Per Share) At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 42 pages 9,500,000 Shares1 Viking Therapeutics, Inc. Common Stock, $0.00001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 7,500,000 Shares1 Viking Therapeutics, Inc. Common Stock, $0.00001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 11,000,000 Shares1 Viking Therapeutics, Inc. Common Stock, $0.00001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 5,130,435 Shares1 Viking Therapeutics, Inc. Common Stock, $0.00001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1
from SC 13G 2 pages Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from S-3 39 pages Viking Therapeutics, Inc. 3,748,726 Shares of Common Stock Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 47 pages Viking Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 47 pages Viking Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages Shares Viking Therapeutics, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 38 pages Shares Viking Therapeutics, Inc. Common Stock Underwriting Agreement
12/34/56